Biotechnology company Allos Therapeutics Inc. said Monday its fourth-quarter loss widened on higher costs associated with sales of the cancer drug Folotyn.
With the acquisition, chemicals will account for 35% of Merck’s revenues and the company will be positioned for expansion in biotechnology. Merck agreed to buy Millipore Corp., a supplier of drug-development equipment for biotechnology companies, for about $6 billion in cash, beating a rival offer from Thermo Fisher Scientific Inc.
Biotechnology company Isis Pharmaceuticals Inc. said Monday its fourth-quarter loss widened on a boost in research and development costs.
Biotechnology company Allos Therapeutics Inc. said Monday its fourth-quarter loss widened on higher costs associated with sales of the cancer drug Folotyn.
Biolexis is a premiere online resource for life sciences professionals, investors and entrepreneurs. The site offers personalized information biotechnology news and other biotechnology resources. Information is further organized by industry sector, therapeutic areas, technology focus, service orientation, and location. With Biolexis, you can: access over 5,000 biotechnology news strories and biotechnology articles. Search biotech company information, biotech news, biotech articles and biotech related press releases.